These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 31605663)
1. Exercise-induced attenuation of treatment side-effects in patients with newly diagnosed prostate cancer beginning androgen-deprivation therapy: a randomised controlled trial. Ndjavera W; Orange ST; O'Doherty AF; Leicht AS; Rochester M; Mills R; Saxton JM BJU Int; 2020 Jan; 125(1):28-37. PubMed ID: 31605663 [TBL] [Abstract][Full Text] [Related]
2. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial. Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669 [TBL] [Abstract][Full Text] [Related]
3. Body composition, fatigue and exercise in patients with prostate cancer undergoing androgen-deprivation therapy. Newton RU; Jeffery E; Galvão DA; Peddle-McIntyre CJ; Spry N; Joseph D; Denham JW; Taaffe DR BJU Int; 2018 Dec; 122(6):986-993. PubMed ID: 29750398 [TBL] [Abstract][Full Text] [Related]
4. Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial. Taaffe DR; Newton RU; Spry N; Joseph D; Chambers SK; Gardiner RA; Wall BA; Cormie P; Bolam KA; Galvão DA Eur Urol; 2017 Aug; 72(2):293-299. PubMed ID: 28249801 [TBL] [Abstract][Full Text] [Related]
5. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Bourke L; Gilbert S; Hooper R; Steed LA; Joshi M; Catto JW; Saxton JM; Rosario DJ Eur Urol; 2014 May; 65(5):865-72. PubMed ID: 24119318 [TBL] [Abstract][Full Text] [Related]
6. Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition. Taaffe DR; Galvão DA; Spry N; Joseph D; Chambers SK; Gardiner RA; Hayne D; Cormie P; Shum DHK; Newton RU BJU Int; 2019 Feb; 123(2):261-269. PubMed ID: 30239116 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial. Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267 [TBL] [Abstract][Full Text] [Related]
8. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer. Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752 [TBL] [Abstract][Full Text] [Related]
9. Prospective study of exercise intervention in prostate cancer patients on androgen deprivation therapy. Beydoun N; Bucci JA; Chin YS; Spry N; Newton R; Galvão DA J Med Imaging Radiat Oncol; 2014; 58(3):369-76. PubMed ID: 24118798 [TBL] [Abstract][Full Text] [Related]
10. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Galvão DA; Spry N; Denham J; Taaffe DR; Cormie P; Joseph D; Lamb DS; Chambers SK; Newton RU Eur Urol; 2014 May; 65(5):856-64. PubMed ID: 24113319 [TBL] [Abstract][Full Text] [Related]
11. Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol. Baguley BJ; Skinner TL; Leveritt MD; Wright OR BMC Cancer; 2017 Jan; 17(1):1. PubMed ID: 28049525 [TBL] [Abstract][Full Text] [Related]
12. A comparison of aerobic- and resistance-emphasised exercise on cardiometabolic health and quality of life in men receiving androgen deprivation therapy for prostate cancer: Protocol for a feasibility trial. Murphy K; Kehoe B; Denieffe S; Hacking D; Fairman CM; Harrison M Contemp Clin Trials; 2024 Jan; 136():107388. PubMed ID: 37972755 [TBL] [Abstract][Full Text] [Related]
13. Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation. McNaught E; Reale S; Bourke L; Brown JE; Collinson M; Day F; Hewison J; Farrin AJ; Ibeggazene S; Innes AQ; Mason E; Meads D; Scope A; Taylor C; Taylor SJ; Turner RR; Rosario DJ; Trials; 2024 Apr; 25(1):257. PubMed ID: 38610058 [TBL] [Abstract][Full Text] [Related]
14. Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients. Wall BA; GALVãO DA; Fatehee N; Taaffe DR; Spry N; Joseph D; Hebert JJ; Newton RU Med Sci Sports Exerc; 2017 Aug; 49(8):1503-1510. PubMed ID: 28319589 [TBL] [Abstract][Full Text] [Related]
15. Home-based versus supervised group exercise in men with prostate cancer on androgen deprivation therapy: A randomized controlled trial and economic analysis. Alibhai SMH; Papadopoulos E; Mina DS; Ritvo P; Tomlinson G; Sabiston CM; Durbano S; Bremner KE; Chiarotto J; Matthew A; Warde P; O'Neill M; Culos-Reed SN J Geriatr Oncol; 2024 Jan; 15(1):101646. PubMed ID: 37976654 [TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND). Harrison MR; Davis PG; Khouri MG; Bartlett DB; Gupta RT; Armstrong AJ; McNamara MA; Zhang T; Anand M; Onyenwoke K; Edwardson S; Craig D; Michalski M; Wu Y; Oyekunle T; Coyne B; Coburn A; Jones LW; George DJ Prostate Cancer Prostatic Dis; 2022 Mar; 25(1):58-64. PubMed ID: 35273377 [TBL] [Abstract][Full Text] [Related]
17. Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT. Alibhai SMH; Ritvo P; Santa Mina D; Sabiston C; Krahn M; Tomlinson G; Matthew A; Lukka H; Warde P; Durbano S; O'Neill M; Culos-Reed SN BMC Cancer; 2018 Oct; 18(1):1031. PubMed ID: 30352568 [TBL] [Abstract][Full Text] [Related]
18. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. Segal RJ; Reid RD; Courneya KS; Malone SC; Parliament MB; Scott CG; Venner PM; Quinney HA; Jones LW; D'Angelo ME; Wells GA J Clin Oncol; 2003 May; 21(9):1653-9. PubMed ID: 12721238 [TBL] [Abstract][Full Text] [Related]
19. A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy. Alibhai SMH; Santa Mina D; Ritvo P; Tomlinson G; Sabiston C; Krahn M; Durbano S; Matthew A; Warde P; O'Neill M; Timilshina N; Segal R; Culos-Reed N BMC Cancer; 2019 Jan; 19(1):2. PubMed ID: 30606137 [TBL] [Abstract][Full Text] [Related]
20. Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis. Yunfeng G; Weiyang H; Xueyang H; Yilong H; Xin G Medicine (Baltimore); 2017 Jul; 96(27):e7368. PubMed ID: 28682886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]